These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10971155)

  • 1. A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: effect on peripheral leukocyte function.
    Alscher DM; Pauli-Magnus C; Kirchgessner J; Kuhlmann U; Mettang T
    Nephron; 2000 Sep; 86(1):62-9. PubMed ID: 10971155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
    Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
    Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.
    Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ
    Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.
    Lage C; Pischetsrieder M; Aufricht C; Jörres A; Schilling H; Passlick-Deetjen J
    Perit Dial Int; 2000; 20 Suppl 5():S28-32. PubMed ID: 11229609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasticizers and inhibition of leukocyte function in vitro.
    Fischer FP; Machleidt C; Rettenmeier AW; Kuhlmann U; Mettang T
    Perit Dial Int; 1998; 18(6):620-5. PubMed ID: 9932661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.
    Liberek T; Topley N; Jörres A; Petersen MM; Coles GA; Gahl GM; Williams JD
    Nephron; 1993; 65(2):260-5. PubMed ID: 8247190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dialysate glucose on phagocyte superoxide generation in CAPD patients.
    Kashem A; Nomoto Y; Tanabe R; Nishina M; Endoh H; Nakajima K; Endoh M; Sakai H; Nakazawa H
    Perit Dial Int; 1998; 18(1):52-9. PubMed ID: 9527030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).
    Lee HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Ahn C; Kim MJ; Shin SK
    Perit Dial Int; 2005; 25(3):248-55. PubMed ID: 15981773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity.
    Thomas S; Schenk U; Fischer FP; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Am J Kidney Dis; 1997 Feb; 29(2):246-53. PubMed ID: 9016897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of amino-acid-based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Schenk U; Kiefer T; Hübel E; Weber J; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Nephron; 1994; 68(3):338-46. PubMed ID: 7838257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Fischer FP; Schenk U; Kiefer T; Hübel E; Thomas S; Yatzidis H; Mettang T; Kuhlmann U
    Am J Kidney Dis; 1995 Dec; 26(6):924-33. PubMed ID: 7503067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.
    Choi HY; Kim DK; Lee TH; Moon SJ; Han SH; Lee JE; Kim BS; Park HC; Choi KH; Ha SK; Han DS; Lee HY
    Perit Dial Int; 2008; 28(2):174-82. PubMed ID: 18332454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
    Mortier S; Faict D; Lameire NH; De Vriese AS
    Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.